Immunoglobulin light-chain amyloidosis shares genetic susceptibility with multiple myeloma

被引：8
|
作者：
Weinhold, N. [1 ]
Foersti, A. [2 ,3 ]
da Silva Filho, M. I. [2 ]
Nickel, J. [1 ]
Campo, C. [2 ]
Hoffmann, P. [4 ,5 ]
Noethen, M. M. [4 ,6 ]
Hose, D. [1 ,7 ]
Goldschmidt, H. [1 ,7 ]
Jauch, A. [8 ]
Langer, C. [9 ]
Hegenbart, U. [1 ]
Schoenland, S. O. [1 ]
Hemminki, K. [2 ,3 ]
机构：
[1] Heidelberg Univ, Dept Internal Med 5, Heidelberg, Germany
[2] German Canc Res Ctr, Heidelberg, Germany
[3] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden
[4] Univ Bonn, Inst Human Genet, Bonn, Germany
[5] Univ Basel, Dept Biomed, Basel, Switzerland
[6] Univ Bonn, Life & Brain Res Ctr, Dept Genom, Bonn, Germany
[7] Natl Ctr Tumor Dis, Heidelberg, Germany
[8] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany
[9] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany
来源：
LEUKEMIA | 2014年 / 28卷 / 11期
关键词：
CYCLIN D1; RISK; POLYMORPHISM; FORMS;
D O I：
10.1038/leu.2014.208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2254 / 2256
页数：4
相关论文
共 26 条
  • [1] Clonal hematopoiesis of indeterminate potential in patients with immunoglobulin light-chain AL amyloidosis
    Lopedote, Paolo
    Evans, Benjamin
    Marchetti, Alfredo
    Chen, Tianzeng
    Moscvin, Maria
    Boullt, Samuel
    Bolli, Niccolo
    Bianchi, Giada
    BLOOD ADVANCES, 2024, 8 (13) : 3427 - 3436
  • [2] Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
    Kumar, Shaji
    Dispenzieri, Angela
    Katzmann, Jerry A.
    Larson, Dirk R.
    Colby, Colin L.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Zeldenrust, Steve R.
    Ramirez-Alvarado, Marina
    Clark, Raynell J.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    BLOOD, 2010, 116 (24) : 5126 - 5129
  • [3] Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma
    da Silva Filho, M. L.
    Foersti, A.
    Weinhold, N.
    Meziane, I.
    Campo, C.
    Huhn, S.
    Nickel, J.
    Hoffmann, P.
    Noethen, M. M.
    Joeckel, K-H
    Landi, S.
    Mitchell, J. S.
    Johnson, D.
    Morgan, G. J.
    Houlston, R.
    Goldschmidt, H.
    Jauch, A.
    Milani, P.
    Merlini, G.
    Rowcieno, D.
    Hawkins, P.
    Hegenbart, U.
    Palladini, G.
    Wechalekar, A.
    Schoenland, S. O.
    Hemminki, K.
    LEUKEMIA, 2017, 31 (08) : 1735 - 1742
  • [4] Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis
    Sharpley, Faye A.
    De-Silva, Dunnya
    Mahmood, Shameem
    Sachchithanantham, Sajitha
    Ramsay, Isobel
    Mingo, Ana Garcia
    Worthington, Sarah
    Hughes, Derralynn
    Mehta, Atul
    Kyriakou, Charalampian
    Griffiths, Paul D.
    Wechalekar, Ashutosh D.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (03) : 230 - 235
  • [5] Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
    Kastritis, Efstathios
    Dialoupi, Ioanna
    Gavriatopoulou, Maria
    Roussou, Maria
    Kanellias, Nikolaos
    Fotiou, Despina
    Ntanasis-Stathopoulos, Ioannis
    Papadopoulou, Elektra
    Ziogas, Dimitrios C.
    Stamatelopoulos, Kimon
    Manios, Efstathios
    Ntalianis, Argyrios
    Eleutherakis-Papaiakovou, Evangelos
    Papanikolaou, Asimina
    Migkou, Magdalini
    Papanota, Aristea-Maria
    Gakiopoulou, Harikleia
    Psimenou, Erasmia
    Tselegkidi, Maria Irini
    Tsitsilonis, Ourania
    Kostopoulos, Ioannis
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD ADVANCES, 2019, 3 (20) : 3002 - 3009
  • [6] Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis
    Stamatelopoulos, Kimon
    Georgiopoulos, Georgios
    Athanasouli, Fani
    Nikolaou, Panagiota-Efstathia
    Lykka, Marita
    Roussou, Maria
    Gavriatopoulou, Maria
    Laina, Aggeliki
    Trakada, Georgia
    Charakida, Marietta
    Delialis, Dimitris
    Petropoulos, Ioannis
    Pamboukas, Constantinos
    Manios, Efstathios
    Karakitsou, Marina
    Papamichael, Christos
    Gatsiou, Aikaterini
    Lambrinoudaki, Irene
    Terpos, Evangelos
    Stellos, Konstantinos
    Andreadou, Ioanna
    Dimopoulos, Meletios A.
    Kastritis, Efstathios
    CIRCULATION RESEARCH, 2019, 125 (08) : 744 - 758
  • [7] Prevalence and Treatment of Arrhythmias in Patients With Transthyretin and Light-Chain Cardiac Amyloidosis
    Miyamoto, Masakazu
    Nakamura, Kazufumi
    Nakagawa, Koji
    Nishii, Nobuhiro
    Kawada, Satoshi
    Ueoka, Akira
    Asada, Saori
    Watanabe, Atsuyuki
    Morita, Hiroshi
    Ito, Hiroshi
    CIRCULATION REPORTS, 2023, 5 (07) : 298 - 305
  • [8] Caspase polymorphisms and genetic susceptibility to multiple myeloma
    Hosgood, H. Dean, III
    Baris, Dalsu
    Zhang, Yawei
    Zhu, Yong
    Zheng, Tongzhang
    Yeager, Meredith
    Welch, Robert
    Zahm, Shelia
    Chanock, Stephen
    Rothman, Nathaniel
    Lan, Qing
    HEMATOLOGICAL ONCOLOGY, 2008, 26 (03) : 148 - 151
  • [9] Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study
    Kyle, Robert A.
    Larson, Dirk R.
    Therneau, Terry M.
    Dispenzieri, Angela
    Melton, L. Joseph, III
    Benson, Joanne T.
    Kumar, Shaji
    Rajkumar, S. Vincent
    LANCET HAEMATOLOGY, 2014, 1 (01): : E28 - E36
  • [10] Pathology and Proteomics-Based Diagnosis of Localized Light-Chain Amyloidosis in Dogs and Cats
    Kadota, Ayumi
    Iwaide, Susumu
    Miyazaki, Shinya
    Mitsui, Ikki
    Machida, Noboru
    Murakami, Tomoaki
    VETERINARY PATHOLOGY, 2020, 57 (05) : 658 - 665
123